The downregulation of interleukin 1 and tumour necrosis factor receptors by topical tacalcitol (1,24(OH)2D3) in psoriasis.
H
H
Mizutani
N
N
Nouchi
M
M
Shimizu
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D004100:Dihydroxycholecalciferols / Q000494:pharmacology*; D015536:Down-Regulation / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000276:immunology*; D018121:Receptors, Cytokine / Q000187:drug effects* / Q000378:metabolism; D017472:Receptors, Interleukin-1 / Q000187:drug effects / Q000378:metabolism; D018124:Receptors, Tumor Necrosis Factor / Q000187:drug effects / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D004100:Dihydroxycholecalciferols; D018121:Receptors, Cytokine; D017472:Receptors, Interleukin-1; D018124:Receptors, Tumor Necrosis Factor; C023850:1 alpha,24-dihydroxyvitamin D3